Condition: Rheumatoid Arthritis · Sponsor: XBiotech, Inc.
Phase II, Double-Blind, Placebo-Controlled, Randomized Trial Examining Natrunix in Combination with MTX (+Folate) for the Treatment of Rheumatoid Arthritis
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Medvin Clinical Research | Covina, California, United States | — |
| T. Joseph Raoof MD, INC | Encino, California, United States | — |
| Desert Medical Advances | Rancho Mirage, California, United States | — |
| Medvin Clinical Research | Riverside, California, United States | — |
| Medvin Clinical Research | Tujunga, California, United States | — |
| Inland Rheumatology Clinical Trials, Inc. | Upland, California, United States | — |
| HARAC Research Corp | Avon Park, Florida, United States | — |
| Reliable Clinical Research, LLC | Hialeah, Florida, United States | — |
| Angels Clinical Research Institute | Miami, Florida, United States | — |
| D&H National Research Centers | Miami, Florida, United States | — |
| BioMed Research & Medical Center, LLC | Miami, Florida, United States | — |
| Advanced Clinical Research of Orlando | Ocoee, Florida, United States | — |
+ 14 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05363891